InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

- Current share price for IDX : $2.120

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$792 Release from Escrow 8 Jul 2021 12:18PM $5.250 $2.120 fallen by 59.62%
$792 Change in substantial holding - IDX 6 Jul 2021 11:26AM $5.190 $2.120 fallen by 59.15%
$792 Release from Escrow 17 Jun 2021 9:23AM $5.130 $2.120 fallen by 58.67%
$792 Ceasing to be a substantial holder 18 May 2021 5:10PM $4.690 $2.120 fallen by 54.80%
$792 Initial Director's Interest Notice - Dr Nazar Bokani 26 Apr 2021 10:09AM $4.790 $2.120 fallen by 55.74%
$792 Executive Director Appointment - Dr Nazar Bokani 16 Apr 2021 12:24PM $4.780 $2.120 fallen by 55.65%
$792 Change of Director's Interest Notice - John Atkin 7 Apr 2021 9:53AM $4.790 $2.120 fallen by 55.74%
$792 Appendix 2A 6 Apr 2021 1:39PM $4.780 $2.120 fallen by 55.65%
$792 Final Director's Interest Notice - Dr Chien Ho 31 Mar 2021 3:22PM $4.750 $2.120 fallen by 55.37%
$792 Update - Dividend/Distribution - IDX 22 Mar 2021 9:47AM $4.560 $2.120 fallen by 53.51%
$792 Correction to ASX Announcement 5 Mar 2021 1:57PM $4.505 $2.120 fallen by 52.94%
$792 Director Retirement - Dr Chien Ho 22 Feb 2021 8:29AM $4.680 $2.120 fallen by 54.70%
$792 Dividend/Distribution - IDX 22 Feb 2021 8:29AM $4.680 $2.120 fallen by 54.70%
$792 Half Year Results Investor Presentation 22 Feb 2021 8:29AM $4.680 $2.120 fallen by 54.70%
$792 Half Year Results Media Release 22 Feb 2021 8:29AM $4.680 $2.120 fallen by 54.70%
$792 Half Yearly Report and Accounts 22 Feb 2021 8:28AM $4.680 $2.120 fallen by 54.70%
$792 FY 21 Half Year Results Release Date & Conference Call 2 Feb 2021 2:01PM $4.590 $2.120 fallen by 53.81%
$792 Release from Escrow 8 Dec 2020 10:26AM $4.080 $2.120 fallen by 48.04%
$792 Change of Director's Interest Notice - Chien Ho 9 Nov 2020 11:47AM $4.350 $2.120 fallen by 51.26%
$792 Appendix 3G - Issue of Equity Incentive Plan Rights 5 Nov 2020 9:22AM $4.280 $2.120 fallen by 50.47%
$792 Results of Annual General Meeting 30 Oct 2020 1:05PM $4.200 $2.120 fallen by 49.52%
$792 Chairman's Address and CEO/MD Presentation to Shareholders 30 Oct 2020 9:03AM $4.120 $2.120 fallen by 48.54%
$792 Change of Director's Interest Notice - John Atkin 2 Oct 2020 1:58PM $4.115 $2.120 fallen by 48.48%
$792 Appendix 2A 1 Oct 2020 12:40PM $4.180 $2.120 fallen by 49.28%
$792 Change of Director's Interest Notice - Chien Ho 24 Sep 2020 12:41PM $4.050 $2.120 fallen by 47.65%

401 - 425 of 789 results

Page 17 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.